Bridging Round

Existing shareholders have played an instrumental part of Good Earth Dairy’s journey to build a scalable camel milk industry and advance its infant formula opportunity.
This round provides new and existing shareholders with the opportunity to help bridge the Company through the final stage of a proposed ~A$15.9M institutional investment and A$4.4M Government-backed infant formula project.

Why This Round Matters

After nearly a decade of development, Good Earth Dairy is approaching a critical stage.

Heads of Agreement has progressed with the Western Australian Government

A proposed institutional transaction is underway

Regulatory and commercial pathways are advancing

This round is not about starting something new, it is about completing what has already been built.

Why Now?

After almost a decade of R&D, herd development, infrastructure design and regulatory advancement, Good Earth Dairy believes it is approaching a pivotal stage in its evolution. Positive Government progression, together with the proposed A$15.9 million institutional transaction, provides a pathway toward large-scale commercialisation. This round is intended to bridge the Company through the final stages of that process

Why Shareholders Originally Invested

Many shareholders first supported Good Earth Dairy when commercially scalable camel milk infant formula was considered highly speculative.

Today:

• ~10 years of R&D completed 
• Government Grant awarded 
• Institutional transaction progressing 
• Commercial products developed 
• Scientific validation confirmed
• Export pathways identified 

Why Camel Milk?

Camel milk is attracting increasing global scientific and commercial interest due to its unique nutritional profile and hypoallergenic properties. Recent peer-reviewed Australian research further supports broader international findings that camel milk possesses a significantly different protein profile to cow milk, including lower allergenic properties, high levels of bioactive peptides and proteins, and characteristics associated with easier digestion. These attributes position camel milk as a compelling foundation for premium nutrition products and next-generation infant formula.
 

Current Progress

• Heads of Agreement signed 
• Positive Government progression achieved 
• London negotiations completed 
• Institutional transaction progressing 
• Existing shareholders have contributed A$122,500 

Current target: additional A$350,000

Use of Funds 

Funds from this raise will be used to: 

• Maintain project momentum 
• Support regulatory and transaction completion activities 
• Preserve operational capability 
• Progress facility planning and project development (spray drier)
• Bridge the Company through final institutional completion processes 

Key Risks

• Future funding may be required to achieve all strategic objectives. 

• Shareholders may experience dilution in future capital raises. 

• Investment returns are not guaranteed. 

• Commercialisation timelines may be affected by regulatory, operational or market factors. 

• Additional unforeseen expenditures may arise as the Company scales. 

For full details, please refer to the Offer Document. 

About Swarmer

Swarmer is an Australian equity crowdfunding platform connecting businesses and investors. Designed to support start-ups, growth companies and scale-ups we allow everyday investors to own a share in businesses that are the future. We hold Australian Financial Services License (AFS License #507867). 

Find out more about becoming a shareholder via Equity Crowdfunding through Swarmer.